Related references
Note: Only part of the references are listed.Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
Hengameh Shams et al.
BRAIN (2023)
How patients with multiple sclerosis acquire disability
Fred D. Lublin et al.
BRAIN (2022)
Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle
Maaike van der Lee et al.
PHARMACOGENOMICS JOURNAL (2022)
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication
Monica Margoni et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2022)
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
Daniel Sandi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+and CD14+cells of multiple sclerosis patients
Ivan Kiselev et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study
Michal Zido et al.
FRONTIERS IN NEUROLOGY (2022)
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Simon Faissner et al.
CNS DRUGS (2022)
Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis
Helena Beatriz Ferreira et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome
Tina Roostaei et al.
NATURE COMMUNICATIONS (2021)
Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis
Amirreza Naseri et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches
Ameneh Jafari et al.
BIOMARKER INSIGHTS (2021)
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
Kathryn C. Fitzgerald et al.
CELL REPORTS MEDICINE (2021)
Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis
Izhak Levi et al.
CELL REPORTS MEDICINE (2021)
Lipidomics from sample preparation to data analysis: a primer
Thomas Zuellig et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2020)
An overview of lipidomic analysis in different human matrices of multiple sclerosis
Helena Beatriz Ferreira et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing-Remitting and Primary Progressive Multiple Sclerosis
Federica Murgia et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Identifying Progression in Multiple Sclerosis: New Perspectives
Massimo Filippi et al.
ANNALS OF NEUROLOGY (2020)
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFN beta
Kirsty E. Waddington et al.
FRONTIERS IN IMMUNOLOGY (2020)
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
Valeria Orru et al.
NATURE GENETICS (2020)
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis
Michael Zhong et al.
NEUROTHERAPEUTICS (2020)
Tissue-specific genetic features inform prediction of drug side effects in clinical trials
Aine Duffy et al.
SCIENCE ADVANCES (2020)
Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis
Petros Pousinis et al.
METABOLITES (2020)
Development and Validation of a Five-Gene Signature to Predict Relapse-Free Survival in Multiple Sclerosis
Fei Ye et al.
FRONTIERS IN NEUROLOGY (2020)
Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis
Benjamin M. Jacobs et al.
BRAIN COMMUNICATIONS (2020)
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS
Till F. M. Andlauer et al.
BMC MEDICINE (2020)
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate
E. Signoriello et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy
Lorena Lorefice et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy
Lorena Lorefice et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Integrated omics: tools, advances and future approaches
Biswapriya B. Misra et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2019)
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
Lorena Lorefice et al.
NEUROTHERAPEUTICS (2019)
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
Stephanie Herman et al.
CELLS (2019)
Genome-wide association study of medication-use and associated disease in the UK Biobank
Yeda Wu et al.
NATURE COMMUNICATIONS (2019)
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
Sahl Khalid Bedri et al.
PLOS ONE (2019)
DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis
Nicole Y. Souren et al.
NATURE COMMUNICATIONS (2019)
A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (vol 10, 2236, 2019)
Lohith Madireddy et al.
NATURE COMMUNICATIONS (2019)
Towards clinical utility of polygenic risk scores
Samuel A. Lambert et al.
HUMAN MOLECULAR GENETICS (2019)
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
Nikolas A. Patsopoulos et al.
SCIENCE (2019)
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
L. Nogueras et al.
SCIENTIFIC REPORTS (2019)
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
Pavan Bhargava et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
A review on machine learning principles for multi-view biological data integration
Yifeng Li et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease
Maria Liguori et al.
HUMAN MOLECULAR GENETICS (2018)
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
Daniel Stoessel et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Dysregulation of methionine metabolism in multiple sclerosis
N. K. Singhal et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Genetic-Driven Druggable Target Identification and Validation
Matteo Floris et al.
TRENDS IN GENETICS (2018)
DNA methylation as a mediator of HLA-DRB1☆15:01 and a protective variant in multiple sclerosis
Lara Kular et al.
NATURE COMMUNICATIONS (2018)
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
Shinya Tasaki et al.
NATURE COMMUNICATIONS (2018)
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients
Damiana Pieragostino et al.
SCIENTIFIC REPORTS (2018)
The relevance of ceramides and their synthesizing enzymes for multiple sclerosis
Jennifer Kurz et al.
CLINICAL SCIENCE (2018)
Top-down proteomic profiling of human saliva in multiple sclerosis patients
Barbara Manconi et al.
JOURNAL OF PROTEOMICS (2018)
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
Amit V. Khera et al.
NATURE GENETICS (2018)
Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study
Irene Moreno-Torres et al.
FRONTIERS IN IMMUNOLOGY (2018)
Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
Bardia Nourbakhsh et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Genome-wide DNA methylation changes in CD19+ B cells from relapsing-remitting multiple sclerosis patients
Vicki E. Maltby et al.
SCIENTIFIC REPORTS (2018)
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS
Arie R. Gafson et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Analytical Challenges and Recent Advances in Mass Spectrometry Based Lipidomics
Yepy H. Rustam et al.
ANALYTICAL CHEMISTRY (2018)
In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis
Ann Cathrine Kroksveen et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma
Besnik Muqaku et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis
Giacomo Lazzarino et al.
MOLECULAR NEUROBIOLOGY (2017)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study
S. Mahurkar et al.
PHARMACOGENOMICS JOURNAL (2017)
Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis
Cecilia Rajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Overexpression of the Cytokine BAFF and Autoimmunity Risk
M. Steri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance
Hyun-Hwi Kim et al.
PLOS ONE (2017)
Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
Chai K. Lim et al.
SCIENTIFIC REPORTS (2017)
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
Colin J. Ross et al.
GENOME MEDICINE (2017)
Differential methylation at MHC in CD4+ T cells is associated with multiple sclerosis independently of HLA-DRB1
Vicki E. Maltby et al.
CLINICAL EPIGENETICS (2017)
Comment: A decade after the metabolomics standards initiative it's time for a revision
Rachel A. Spicer et al.
SCIENTIFIC DATA (2017)
Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment
Maria Jesus Pinto-Medel et al.
SCIENTIFIC REPORTS (2017)
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation
Pavan Bhargava et al.
JCI INSIGHT (2017)
Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis
Marcella Reale et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Oxidative stress-related biomarkers in multiple sclerosis: a review
Richard Ibitoye et al.
BIOMARKERS IN MEDICINE (2016)
Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapies
Chiara Cordiglieri et al.
CLINICAL IMMUNOLOGY (2016)
Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis
Yu Jiang et al.
GENOMICS (2016)
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica
Teklab Gebregiworgis et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs
Ekaterina Tsareva et al.
PHARMACOGENETICS AND GENOMICS (2016)
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
Aurelie Kamoun et al.
NATURE COMMUNICATIONS (2016)
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+T cells
Katherine A. Sanders et al.
CLINICAL EPIGENETICS (2016)
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation
Till F. M. Andlauer et al.
SCIENCE ADVANCES (2016)
1H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
Eleonora Cocco et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses
O. G. Kulakova et al.
ACTA NATURAE (2016)
Serum proteomics in multiple sclerosis disease progression
Helen Tremlett et al.
JOURNAL OF PROTEOMICS (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Machine learning applications in genetics and genomics
Maxwell W. Libbrecht et al.
NATURE REVIEWS GENETICS (2015)
Genome-wide DNA methylation profiling of CD8+T cells shows a distinct epigenetic signature to CD4+T cells in multiple sclerosis patients
Vicki E. Maltby et al.
CLINICAL EPIGENETICS (2015)
Remyelination Therapy in Multiple Sclerosis
Danielle E. Harlow et al.
FRONTIERS IN NEUROLOGY (2015)
Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort
M. T. Wallin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Influence of treatments in multiple sclerosis disability: A cohort study
Eleonora Cocco et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Genome-Wide DNA Methylation Profiles Indicate CD8+T Cell Hypermethylation in Multiple Sclerosis
Steffan D. Bos et al.
PLOS ONE (2015)
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β
Bruna De Felice et al.
BMC MEDICAL GENOMICS (2014)
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics
Oscar G. Vidaurre et al.
BRAIN (2014)
Sphingolipids: Important Players in Multiple Sclerosis
Ramona Halmer et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season
Grant P. Parnell et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Methylation differences at the HLA-DRBI locus in CD4+T-Cells are associated with multiple sclerosis
M. C. Graves et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis
S. N. Reinke et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
The clinical potential of blood-proteomics in multiple sclerosis
Roberto De Masi et al.
BMC NEUROLOGY (2013)
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
Michael Hecker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance
Masoud Mehrpour et al.
MAGNETIC RESONANCE IN CHEMISTRY (2013)
Transcriptome and genome sequencing uncovers functional variation in humans
Tuuli Lappalainen et al.
NATURE (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
Validating therapeutic targets through human genetics
Robert M. Plenge et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes
Ruben van Doorn et al.
ACTA NEUROPATHOLOGICA (2012)
Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis
Pablo Villoslada et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
The discovery and development of belimumab: the anti-BLyS-lupus connection
William Stohl et al.
NATURE BIOTECHNOLOGY (2012)
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
Nikolaos A. Patsopoulos et al.
ANNALS OF NEUROLOGY (2011)
Oxidative damage in multiple sclerosis lesions
Lukas Haider et al.
BRAIN (2011)
Differential Expression of Complement Proteins in Cerebrospinal Fluid From Active Multiple Sclerosis Patients
Yun Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis
Piero Del Boccio et al.
JOURNAL OF PROTEOMICS (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Glatiramer Acetate A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
Natalie J. Carter et al.
DRUGS (2010)
Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis
Michael J. Chao et al.
HUMAN MOLECULAR GENETICS (2010)
Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: Proteomic analysis
Setsu Sawai et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis
Serena Sanna et al.
NATURE GENETICS (2010)
Sphingolipids in Multiple Sclerosis
Arundhati Jana et al.
NEUROMOLECULAR MEDICINE (2010)
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
Philip L. De Jager et al.
LANCET NEUROLOGY (2009)
Very long chain fatty acid levels in patients diagnosed with multiple sclerosis
Alastair Wilkins et al.
MULTIPLE SCLEROSIS (2009)
Effect of anti-IFNβ antibodies on MRI lesions of MS patients in the BECOME study
Andrew R. Pachner et al.
NEUROLOGY (2009)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inflammatory Multiple-Sclerosis Plaques Generate Characteristic Metabolic Profiles in Cerebrospinal Fluid
Norbert W. Lutz et al.
PLOS ONE (2007)
Oxidative stress kills human primary Oligodendrocytes via neutral sphingomyelinase: Implications for multiple sclerosis
Arundhati Jana et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Proteomic analysis of human activated by multiple sclerosis cerebral endothelial cells serum and IFNβ-1b
J. Steven Alexander et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis
Sergio E. Baranzini
AUTOIMMUNITY (2006)
Share Paper
